Protalix BioTherapeutics, Inc. (FRA:PBDA)
Germany · Delayed Price · Currency is EUR 1.510
-0.040 (-2.58%)
At close: Nov 28, 2025
Protalix BioTherapeutics Market Cap
Protalix BioTherapeutics has a market cap or net worth of €117.6 million as of December 1, 2025. Its market cap has increased by 28.54% in one year.
Market Cap
117.60M
Enterprise Value
99.37M
Revenue
52.71M
Ranking
n/a
PE Ratio
25.58
Stock Price
€1.51
Market Cap Chart
Since January 3, 2007, Protalix BioTherapeutics's market cap has increased from 6.34M to 117.60M, an increase of 1,753.94%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 123.45M | -7.67% |
| Dec 31, 2024 | 133.71M | 13.82% |
| Dec 29, 2023 | 117.48M | 80.88% |
| Dec 30, 2022 | 64.95M | 94.95% |
| Dec 31, 2021 | 33.32M | -65.61% |
| Dec 31, 2020 | 96.87M | 123.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |